[Methods in Molecular Biology] Gene Therapy for Neurological Disorders Volume 1382 ||Manfredsson, Fredric P. · 2016

The development of flexible lentiviral vectors for gene transfer in the CNSFredric P. Manfredsson; Ronald J. Mandel · 2011

[Methods in Molecular Biology] Gene Therapy for Neurological Disorders Volume 1382 || Regulated Gene TherapyManfredsson, Fredric P. · 2016

[Methods in Molecular Biology] Gene Therapy for Neurological Disorders Volume 1382 || Lentivirus Production and PurificationManfredsson, Fredric P. · 2016

[Methods in Molecular Biology] Gene Therapy for Neurological Disorders Volume 1382 || Viral Vector Production: AdenovirusManfredsson, Fredric P. · 2016

Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesiaSteece‐Collier, Kathy; Stancati, Jennifer A.; Collier, Nicholas J.; Sandoval, Ivette M.; Mercado, Natosha M.; Sortwell, Caryl E.; Collier, Timothy J.; Manfredsson, Fredric P. · Movement Disorders · 2019

Regulated protein expression for in vivo gene therapy for neurological disorders: Progress, strategies, and issuesFredric P. Manfredsson; David C. Bloom; Ronald J. Mandel · 2012

The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseaseBenskey, Matthew J.; Perez, Ruth G.; Manfredsson, Fredric P. · Journal of Neurochemistry · 2016